Skip to main content
. 2022 Jan 28;17:8. doi: 10.1186/s13017-022-00407-1

Table 2.

Treatment of the patients and its outcome and variations between the two periods of the study

Factor 2019* 2020* Absolute variation§ P
Treatment
Medical 1175 (30.8%) 808 (33.0%) − 31.2% 0.12282
Surgical 2391 (62.8%) 1505 (61.4%) − 37.1%
Interventional 244 (6.4%) 137 (5.6%) − 43.9%
Missing 0 3
Surgical access
Laparoscopic 952 (42.7%) 559 (40.4%) − 41.3% 0.11324
Open 1257 (56.4%) 818 (59.1%) − 34.9%
Lap converted to open 19 (0.8%) 6 (0.4%) − 68.4%
Missing 171 107
Lap-to-open conversion 19/971 (2.0%) 6/565 (1.1%) − 45.0% 0.18140
Surgical subspecialty
Colorectal 1307 (54.9%) 809 (53.9%) − 38.1% 0.00603
Upper GI 85 (3.6%) 70 (4.7%) − 17.6%
HPB 416 (17.5%) 256 (17.1%) − 38.5%
Abdominal wall 281 (11.8%) 150 (10.0%) − 46.6%
I&D of abscesses 138 (5.8%) 98 (6.5%) − 29.0%
Chest 35 (1.5%) 13 (0.9%) − 62.9%
Vascular 21 (0.9%) 11 (0.7%) − 47.6%
Urology/Gynae 14 (0.6%) 7 (0.5%) − 50.0%
Other 82 (3.4%) 87 (5.8%) + 6.1%
Missing 12 4
Length of stay 7.8±10.5 7.7±10.0 − 1.5% 0.65716
Reoperation
No 3457 (96.6%) 2334 (96.6%) − 32.5% 0.93414
Yes 120 (3.4%) 82 (3.4%) − 31.7%
Missing 233 37
Readmission
No 3398 (91.0%) 2247 (92.4%) − 33.9% 0.05906
Yes 335 (9.0%) 185 (7.6%) − 44.8%
Missing 77 21

*: values are reported as: total number (relative percentage in the column)

§: values represent the absolute variation of cases between March-April 2019 and March-April 2020

§: in bold p < 0.05